Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Enrolling by invitation × durvalumab × Tumor-Agnostic × Clear all

Phase

Status

Recruiting 4 Completed 4 Active not recruiting 2 Terminated 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1 Thoracic 1

Conditions

Interventions

gallium 68 PSMA-11 1 durvalumab 1 Specimen Handling 1 Protons 1 Photons 1 Community Health Workers 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05303532 2026-02-23

ROSY-D

AstraZeneca

Phase 3 Enrolling by invitation

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡